MD Revolution Inc.
$23 Million - Private PlacementExclusive Placement Agent
WAVE Life Sciences
$102 Million - Initial Public OfferingJoint Bookrunner
Kura Oncology, Inc.
$50 Million - Equity OfferingJoint Bookrunner
Major Rx Pricing Reform Unlikely; CMS Pilot Programs Benign
MEDACorp Survey and Our Analysis Suggests Orphan Drug Pricing Concerns Overdone
Managed Care/ Why the Cadillac Tax Is Evolutionary Not Revolutionary; “Big 3” Well-Prepared